Search - tctmd.com

Displaying 661 - 680 of 20307

Sort: Relevancy | Date

Presentation NY Valves 2025

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Presenter: Suzanne V. Arnold

June 26, 2025

Presentation NY Valves 2025

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Presenter: Ogechukwu Samuel Obi

June 26, 2025

Presentation NY Valves 2025

Best Practices for Choosing Amulet Occluder Size for Optimal Outcomes

Presenter: Jacqueline Saw

June 26, 2025

Presentation NY Valves 2025

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Presenter: Paul A. Grayburn

June 26, 2025

Presentation NY Valves 2025

Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Tamari Lomaia

June 26, 2025

Presentation NY Valves 2025

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

Presenter: Gagan D. Singh

June 26, 2025

Presentation NY Valves 2025

MonarQ TTVR System: Technology Update and Early Clinical Experience

Presenter: Arshad Quadri

June 26, 2025

Presentation NY Valves 2025

How To Determine the Optimal Transseptal Puncture Site for the Watchman Procedure

Presenter: Rodney Horton

June 26, 2025

Presentation NY Valves 2025

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Presenter: Matthew J. Price

June 26, 2025

Presentation NY Valves 2025

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Presenter: Gregory P. Fontana

June 26, 2025

Presentation NY Valves 2025

Unexpected Migration of a MitraClip: Clinical Challenges and Lessons Learned

Presenter: Salman Khalid

June 26, 2025

Presentation NY Valves 2025

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Presenter: Sreekanth Vemulapalli

June 26, 2025

Presentation NY Valves 2025

Patient Selection for TTVR: Clinical/Physiologic Considerations

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

Presenter: Tamim M. Nazif

June 26, 2025

Presentation NY Valves 2025

How Many Clinical Phenotypes?

Presenter: Dharam J. Kumbhani

June 26, 2025

Presentation NY Valves 2025

Clip Laceration to Faciliate Transcatheter Tricsupid Valve Replacement (Evoque): When & How

Presenter: Pradeep K. Yadav

June 26, 2025

Presentation NY Valves 2025

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Presenter: David J. Cohen

June 26, 2025

Presentation NY Valves 2025

The AMEND Transcatheter Mitral Valve Annuloplasty System: Early Human Clinical Experience (Valcare)

Presenter: Federico De Marco

June 26, 2025

Presentation NY Valves 2025

MAYBE, Lets Also Consider the OUS Registry Data

Presenter: Ralph Stephan von Bardeleben

June 26, 2025

Presentation NY Valves 2025

NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

Presenter: Sanjay Kaul

June 26, 2025

Advertisement

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

Best Practices for Choosing Amulet Occluder Size for Optimal Outcomes

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Recognizing When a Watchman Result is Not Good Enough: Making Sense of Shoulders, Gutters, Fabric Leaks, and Various Device Shapes

MonarQ TTVR System: Technology Update and Early Clinical Experience

How To Determine the Optimal Transseptal Puncture Site for the Watchman Procedure

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Unexpected Migration of a MitraClip: Clinical Challenges and Lessons Learned

What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?

Patient Selection for TTVR: Clinical/Physiologic Considerations

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

How Many Clinical Phenotypes?

Clip Laceration to Faciliate Transcatheter Tricsupid Valve Replacement (Evoque): When & How

What Are the Next Clinical Trials Needed in the Tricuspid Space?

The AMEND Transcatheter Mitral Valve Annuloplasty System: Early Human Clinical Experience (Valcare)

MAYBE, Lets Also Consider the OUS Registry Data

NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content